Similar articles for PMID: 11839731

Year	Number of Results
2001	1
2002	2
2003	4
2004	2
2005	4
2006	5
2007	3
2008	8
2009	4
2010	2
2011	6
2012	5
2013	2
2014	3
2015	2
2016	4
2017	1
2018	4
2019	1
2024	0

1

Mucosal barrier function and the commensal flora.

Kennedy RJ, Kirk SJ, Gardiner KR. Kennedy RJ, et al. Gut. 2002 Mar;50(3):441-2. doi: 10.1136/gut.50.3.441. Gut. 2002. PMID: 11839731 Free PMC article. No abstract available.

2

Probiotics and barrier function in colitis.

Gionchetti P, Lammers KM, Rizzello F, Campieri M. Gionchetti P, et al. Gut. 2005 Jul;54(7):898-900. doi: 10.1136/gut.2004.060640. Gut. 2005. PMID: 15951530 Free PMC article. Review.

3

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.

Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH. Zeng J, et al. Aliment Pharmacol Ther. 2008 Oct 15;28(8):994-1002. doi: 10.1111/j.1365-2036.2008.03818.x. Epub 2008 Jul 30. Aliment Pharmacol Ther. 2008. PMID: 18671775 Free article. Clinical Trial.

4

The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.

Persborn M, Gerritsen J, Wallon C, Carlsson A, Akkermans LM, Söderholm JD. Persborn M, et al. Aliment Pharmacol Ther. 2013 Oct;38(7):772-83. doi: 10.1111/apt.12451. Epub 2013 Aug 19. Aliment Pharmacol Ther. 2013. PMID: 23957603 Free article. Clinical Trial.

5

Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial.

Jain PK, McNaught CE, Anderson AD, MacFie J, Mitchell CJ. Jain PK, et al. Clin Nutr. 2004 Aug;23(4):467-75. doi: 10.1016/j.clnu.2003.12.002. Clin Nutr. 2004. PMID: 15297081 Clinical Trial.

6

Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.

Toumi R, Abdelouhab K, Rafa H, Soufli I, Raissi-Kerboua D, Djeraba Z, Touil-Boukoffa C. Toumi R, et al. Immunopharmacol Immunotoxicol. 2013 Jun;35(3):403-9. doi: 10.3109/08923973.2013.790413. Epub 2013 May 2. Immunopharmacol Immunotoxicol. 2013. PMID: 23638770

7

Probiotics and inflammatory bowel diseases.

Bai AP, Ouyang Q. Bai AP, et al. Postgrad Med J. 2006 Jun;82(968):376-82. doi: 10.1136/pgmj.2005.040899. Postgrad Med J. 2006. PMID: 16754706 Free PMC article. Review.

8

Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.

Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V. Barbara G, et al. J Clin Gastroenterol. 2012 Oct;46 Suppl:S52-5. doi: 10.1097/MCG.0b013e318264e918. J Clin Gastroenterol. 2012. PMID: 22955358

9

What is the role of the enteric commensal flora in IBD?

Guarner F. Guarner F. Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S83-4. doi: 10.1002/ibd.20548. Inflamm Bowel Dis. 2008. PMID: 18816773 No abstract available.

10

Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.

Camilleri M. Camilleri M. J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 1:S123-5. doi: 10.1097/MCG.0b013e3181574393. J Clin Gastroenterol. 2008. PMID: 18806702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year